148 related articles for article (PubMed ID: 24034482)
1. An updated systematic review of the role of host genetics in susceptibility to influenza.
Horby P; Nguyen NY; Dunstan SJ; Kenneth Baillie J
Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):37-41. PubMed ID: 24034482
[TBL] [Abstract][Full Text] [Related]
2. IFITM3: How genetics influence influenza infection demographically.
Wellington D; Laurenson-Schafer H; Abdel-Haq A; Dong T
Biomed J; 2019 Feb; 42(1):19-26. PubMed ID: 30987701
[TBL] [Abstract][Full Text] [Related]
3. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H
Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783
[TBL] [Abstract][Full Text] [Related]
4. The role of host genetics in susceptibility to influenza: a systematic review.
Horby P; Nguyen NY; Dunstan SJ; Baillie JK
PLoS One; 2012; 7(3):e33180. PubMed ID: 22438897
[TBL] [Abstract][Full Text] [Related]
5. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
Allen EK; Randolph AG; Bhangale T; Dogra P; Ohlson M; Oshansky CM; Zamora AE; Shannon JP; Finkelstein D; Dressen A; DeVincenzo J; Caniza M; Youngblood B; Rosenberger CM; Thomas PG
Nat Med; 2017 Aug; 23(8):975-983. PubMed ID: 28714988
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Yang X; Tan B; Zhou X; Xue J; Zhang X; Wang P; Shao C; Li Y; Li C; Xia H; Qiu J
PLoS One; 2015; 10(5):e0124985. PubMed ID: 25942469
[TBL] [Abstract][Full Text] [Related]
7. Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Prabhu SS; Chakraborty TT; Kumar N; Banerjee I
Gene; 2018 Oct; 674():70-79. PubMed ID: 29940276
[TBL] [Abstract][Full Text] [Related]
8. Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
Carter TC; Hebbring SJ; Liu J; Mosley JD; Shaffer CM; Ivacic LC; Kopitzke S; Stefanski EL; Strenn R; Sundaram ME; Meece J; Brilliant MH; Ferdinands JM; Belongia EA
J Med Virol; 2018 Mar; 90(3):436-446. PubMed ID: 29053189
[TBL] [Abstract][Full Text] [Related]
9.
Pan Y; Yang P; Dong T; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Wang Q
Front Cell Infect Microbiol; 2017; 7():294. PubMed ID: 28713779
[No Abstract] [Full Text] [Related]
10. Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Randolph AG; Yip WK; Allen EK; Rosenberger CM; Agan AA; Ash SA; Zhang Y; Bhangale TR; Finkelstein D; Cvijanovich NZ; Mourani PM; Hall MW; Su HC; Thomas PG; ;
J Infect Dis; 2017 Jul; 216(1):14-21. PubMed ID: 28531322
[TBL] [Abstract][Full Text] [Related]
11. IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Xuan Y; Wang LN; Li W; Zi HR; Guo Y; Yan WJ; Chen XB; Wei PM
Epidemiol Infect; 2015 Oct; 143(14):2975-84. PubMed ID: 25778715
[TBL] [Abstract][Full Text] [Related]
12. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus.
Kim YC; Jeong BH
Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121
[TBL] [Abstract][Full Text] [Related]
13. Strong association of regulatory single nucleotide polymorphisms (SNPs) of the IFITM3 gene with influenza H1N1 2009 pandemic virus infection.
Kim YC; Jeong MJ; Jeong BH
Cell Mol Immunol; 2020 Jun; 17(6):662-664. PubMed ID: 31685927
[No Abstract] [Full Text] [Related]
14. Differential Leukocyte Expression of
Regino-Zamarripa NE; Ramírez-Martínez G; Jiménez-Álvarez LA; Cruz-Lagunas A; Gómez-García IA; Ignacio-Cortés S; Márquez-García JE; Pacheco-Hernández LM; Ramírez-Noyola JA; Barquera R; Mendoza-Milla C; Luna-Rivero C; Domínguez-Cherit JG; Ramírez-Rangel R; Rodríguez-Reyna TS; Hernández-Cárdenas CM; Choreño-Parra JA; León-Ávila G; Zúñiga J
J Interferon Cytokine Res; 2022 Aug; 42(8):430-443. PubMed ID: 35708622
[TBL] [Abstract][Full Text] [Related]
15. IFITM3 and severe influenza virus infection. No evidence of genetic association.
López-Rodríguez M; Herrera-Ramos E; Solé-Violán J; Ruíz-Hernández JJ; Borderías L; Horcajada JP; Lerma-Chippirraz E; Rajas O; Briones M; Pérez-González MC; García-Bello MA; López-Granados E; Rodriguez de Castro F; Rodríguez-Gallego C
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1811-1817. PubMed ID: 27492307
[TBL] [Abstract][Full Text] [Related]
16. Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Gaio V; Nunes B; Pechirra P; Conde P; Guiomar R; Dias CM; Barreto M
PLoS One; 2016; 11(6):e0158181. PubMed ID: 27351739
[TBL] [Abstract][Full Text] [Related]
17. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.
Yount JS; Karssemeijer RA; Hang HC
J Biol Chem; 2012 Jun; 287(23):19631-41. PubMed ID: 22511783
[TBL] [Abstract][Full Text] [Related]
18. IFITM3 and susceptibility to respiratory viral infections in the community.
Mills TC; Rautanen A; Elliott KS; Parks T; Naranbhai V; Ieven MM; Butler CC; Little P; Verheij T; Garrard CS; Hinds C; Goossens H; Chapman S; Hill AV
J Infect Dis; 2014 Apr; 209(7):1028-31. PubMed ID: 23997235
[TBL] [Abstract][Full Text] [Related]
19. Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Makvandi-Nejad S; Laurenson-Schafer H; Wang L; Wellington D; Zhao Y; Jin B; Qin L; Kite K; Moghadam HK; Song C; Clark K; Hublitz P; Townsend AR; Wu H; McMichael AJ; Zhang Y; Dong T
J Infect Dis; 2018 Jan; 217(2):257-262. PubMed ID: 29202190
[TBL] [Abstract][Full Text] [Related]
20. IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.
Lanz C; Schotsaert M; Magnus C; Karakus U; Hunziker A; Sempere Borau M; Martínez-Romero C; Spieler EE; Günther SC; Moritz E; Hale BG; Trkola A; García-Sastre A; Stertz S
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33882122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
